ISORDIL 5MG TABLET 10'S

ISORDIL 5MG TABLET 10'S belongs to a group of medicines called organic nitrates. ISORDIL 5MG TABLET 10'S is used to prevent and treat angina pectoris and as an adjunctive treatment in severe acute or chronic congestive cardiac failure.

ISORDIL 5MG TABLET 10'S works by widening the blood vessels in your heart to allow an increased amount of blood flow to areas which need it.

No, ISORDIL 5MG TABLET 10'S does not lower heart rate. However, in some cases, one may experience reflex tachycardia (fast heart rate) while using nitrates such as ISORDIL 5MG TABLET 10'S.

Yes, ISORDIL 5MG TABLET 10'S lowers blood pressure. This medicine widens the blood vessels and decreases the resistance in them, causing a fall in blood pressure. This fall in blood pressure may in turn decrease the heartbeat which can lead to angina. This medicine should be avoided in people who already have low blood pressure. Discuss with your doctor if you have any concerns.

No, you should not take sildenafil along with ISORDIL 5MG TABLET 10'S. Both these medicines lower blood pressure and belong to the same class. Taking these two medicines together may cause significant decrease in blood pressure which can cause fainting or even a heart attack. Along with this, avoid taking other medicines which belong to the same class such as vardenafil and tadalafil.

Isordil 5 is a medicine containing isosorbide dinitrate 5 mg, a nitrate vasodilator. It is primarily used for the prevention and long‑term management of angina pectoris (chest pain) caused by reduced blood flow to the heart muscle in coronary artery disease. It helps decrease the heart’s workload and improve oxygen supply by dilating blood vessels.

Isordil 5 releases nitric oxide in vascular smooth muscle, which activates guanylate cyclase and increases cyclic GMP levels. This leads to relaxation and dilation of veins and, to a lesser extent, arteries. Venous dilation reduces venous return (preload), while arterial dilation lowers systemic vascular resistance (afterload). Together, these effects reduce myocardial oxygen demand and can improve coronary blood flow, relieving anginal symptoms.

Isordil 5 is generally used for prophylaxis and chronic management of angina rather than for rapid relief of an acute attack, unless a clinician has specifically prescribed it for that purpose and in an appropriate formulation. For sudden chest pain, short‑acting sublingual nitrates are usually preferred. Patients experiencing new or severe chest pain should seek urgent medical attention rather than relying on chronic nitrate therapy alone.

Common side effects include headache, flushing, dizziness, light‑headedness, weakness, and a feeling of warmth, all related to vasodilation. Orthostatic hypotension (a drop in blood pressure when standing), palpitations, and reflex tachycardia may also occur. These effects are often more noticeable when treatment is started or doses are changed and may lessen with continued use. Any severe, persistent, or unusual symptoms should be reported to a healthcare professional.

Isordil 5 is contraindicated in individuals with known hypersensitivity to isosorbide dinitrate, other organic nitrates, or any excipients in the product. It should not be used in patients taking phosphodiesterase‑5 inhibitors (such as sildenafil, tadalafil, or vardenafil) or soluble guanylate cyclase stimulators (such as riociguat) due to the risk of profound hypotension. It is generally avoided in patients with severe hypotension, shock, marked anemia, or significantly increased intracranial pressure. Suitability must always be assessed by a clinician.

No. Isordil 5 must not be taken together with erectile dysfunction medicines that are phosphodiesterase‑5 inhibitors (for example, sildenafil, tadalafil, or vardenafil). Both drug classes enhance nitric oxide–mediated vasodilation and can cause a dangerous, potentially life‑threatening drop in blood pressure when combined. Patients should inform their healthcare provider about any current or planned use of such medicines so that safe alternatives can be considered.

If you feel dizzy, light‑headed, or faint after taking Isordil 5, sit or lie down immediately to reduce the risk of falling. Elevating the legs may help if symptoms are due to low blood pressure. Do not drive or operate machinery while symptomatic. If the dizziness is severe, persists, or is associated with chest pain, shortness of breath, or loss of consciousness, seek urgent medical attention. Inform your prescriber, as your dose or regimen may need adjustment.

Alcohol can enhance the blood pressure‑lowering and dizziness‑inducing effects of Isordil 5. Concomitant use may increase the risk of marked hypotension, fainting, and impaired alertness. It is generally advisable to avoid or strictly limit alcohol intake while on this medicine. Patients who choose to drink should do so only after discussing it with their healthcare provider and should monitor for symptoms such as dizziness or light‑headedness.

Data on the use of isosorbide dinitrate in pregnancy and breastfeeding are limited. Isordil 5 should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as determined by a specialist. It is not known to what extent isosorbide dinitrate or its metabolites are excreted in human breast milk. A clinician will weigh the benefits of therapy for the mother against any potential risk to the breastfed infant and may recommend monitoring, dose adjustment, or an alternative treatment.

Isordil 5 should not be stopped abruptly without medical advice, especially in patients with established coronary artery disease. Sudden discontinuation may lead to rebound angina or worsening of underlying ischemia. If your symptoms improve, this usually reflects effective control rather than cure of the underlying condition. Any change in dose or discontinuation should be done gradually and under the supervision of your healthcare provider, who will reassess your cardiovascular status and overall treatment plan.